Abstract
John's talk focused on his experiences working with bioactivity data and drug discovery research along with some of the problems and errors that people have encountered when working in this sphere. In the past researchers could reasonably know ‘most' of the research within a field, but now we have much larger scale research, more participants and more data but without a lot of the groundwork being laid for good data sharing and reusability. Now there is a lot of messy data out there; inaccessible data, cryptic data and poorly described data. John talks about some of the bioactivity resources that are available for researchers and some of the successes that these data sources have had when handling large amounts of data. John gives plenty of tips about things to look out for when examining chemical and biological data, with plenty of examples.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
